Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68860-35-5

Post Buying Request

68860-35-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68860-35-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 68860-35-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,8,6 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 68860-35:
(7*6)+(6*8)+(5*8)+(4*6)+(3*0)+(2*3)+(1*5)=165
165 % 10 = 5
So 68860-35-5 is a valid CAS Registry Number.

68860-35-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(triphenylphosphoniummethyl)salicylaldehyde monochloride

1.2 Other means of identification

Product number -
Other names (3-formyl-4-hydroxy-benzyl)-triphenyl-phosphonium, chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68860-35-5 SDS

68860-35-5Downstream Products

68860-35-5Relevant articles and documents

Zinc (II) complex with a cationic Schiff base ligand: Synthesis, characterization, and biological studies

Lee, Sze Koon,Tan, Kong Wai,Ng, Seik Weng,Ooi, Kah Kooi,Ang, Kok Pian,Abdah, Md Akim

, p. 101 - 108 (2014)

A cationic Schiff base ligand, TSB (L) and its Zn (II) complex (1) were synthesized and characterized by using CHN, 1H-NMR, FT-IR, UV, LC-MS, and X-ray methods. Their ability to inhibit topoisomerase I, DNA cleavage activities, and cytotoxicity

Benzimidazole derivative and 8-hydroxyquinoline derivative cadmium complex dye sensitizer as well as preparation method and application thereof

-

, (2021/01/24)

The invention relates to a D (-A-pi-A) 2 type benzimidazole derivative and 8-hydroxyquinoline derivative cadmium complex dye sensitizer (BDTT-bi-Cd) as shown in a formula 1 as well as a preparation method and application of the BDTT-bi-Cd. The dye sensitizer is a D (-A-pi-A) 2 type complex synthesized by reacting benzimidazole containing functional groups such as an auxiliary electron acceptor (A), a pi bridge, a main electron acceptor (A) and an anchoring group with a 8-hydroxyquinoline derivative cadmium complex and an electron donor (D) benzodithiophene bithiophene (BDTT) through a Heck coupling reaction. Experiments show that the photovoltaic performance test of a dye-sensitized solar cell with the BDTT-bi-Cd as the dye sensitizer shows good effects that the photoelectric conversion efficiency (PCE) reaches 8.40%, the dye thermal decomposition temperature reaches 320 DEG C or above, the thermal stability is high, the requirements of photovoltaic materials can be met, and the complex dye sensitizer has a certain prospect in the aspect of development and application of the dye-sensitized solar cell. The structure of the complex BDTT-bi-Cd shown in the formula 1 is shown in the specification.

Sterol regulatory element binding protein and acidic nucleoplasm DNA binding protein-1 inhibitor, preparation method and application thereof

-

, (2020/07/13)

The invention discloses a compound which is shown as formula I and can inhibit sterol regulatory element binding protein (Srebp) and acidic nucleoplasm DNA binding protein-1 (And-1, WDHD1), a preparation method and application thereof. RT-PCR (reverse transcription-polymerase chain reaction) and immunoblotting experiments show that the compound can remarkably reduce the expression of a Srebp downstream gene SCD-1 and inhibit the activity of And-1 protein. Further experiments show that the compound has a proliferation inhibition effect on various tumor cells. The compound shown as formula I isexpected to become a novel anti-tumor drug and a tumor chemoradiotherapy sensitizing drug.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68860-35-5